Regdanvimab improves disease mortality and morbidity in patients with COVID-19: A meta-analysis

Affiliations

• ¹ West China Fourth Hospital/West China School of Public Health, Sichuan University, Chengdu, Sichuan, China; Health Emergency Management Research Center, China-PUMC C.C. Chen Institute of Health, Sichuan University, Chengdu, Sichuan, China.
• ² School of Medicine, Queen's University, Kingston, Canada.
• ³ Department of Urology, Chengdu First People's Hospital, Chengdu, Sichuan, China.
• ⁴ Chengdu West China Clinical Research Center, Chengdu, Sichuan, China.
• ⁵ Schulich School of Medicine & Dentistry, Western University, London, Canada.
• ⁶ Department of Nephrology, Chengdu First People's Hospital, No.18 Wanxiang North Road, High-tech District, Chengdu, Sichuan 610095, China. Electronic address: agy1990418@163.com.